Aspen Pharmacare Holdings Limited

Aspen Pharmacare Holdings Limited

APNHF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$4.45B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Aspen Pharmacare Holdings LimitedAspen Pharmacare Holdings Limited29.61.31%2%0.10.2
$4.93

Current Fair Value

50.9% downside

Overvalued by 50.9% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$4.45 Billion
Enterprise Value$4.03 Billion
Annual dividend$0.14
Dividend yield1.31%
Earnings per Share$5.96
Beta0.34
Outstanding Shares443,480,000

Return

Return on Equity1.92%ROE
Return on Assets1.43%
Return on Invested Capital6.48%

Valuation & Multiples

P/E Ratio29.61P/E Ratio
PEG-21.94PEG
Price to Sales0.06Price to Sales
Price to Book Ratio0.06Price to Book Ratio
Enterprise Value to Revenue0.05
Enterprise Value to EBIT0.68
Enterprise Value to Net Income2
Total Debt to Enterprise3.84
Debt to Equity0.19Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
September 2, 2026
EPS
$0.17
Reported
Revenue
$1.13 B
Reported

Next Earnings Call

Expected Date
March 11, 2027
EPS Estimate
-
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Aspen Pharmacare Holdings Ltd

9,557 employees
CEO: Stephen Saad

Operating worldwide, Aspen Pharmacare Holdings Limited, together with its subsidiaries, focuses on the development, production, and global distribution of specialized and branded pharmaceutical products. The company's business activities...